Suntory Pharmaceutical   Report issue

For profit Phase 2 Phase 3
Founded: Osaka Japan (1899)
Status: Left NME R&D (2011)

Organization Overview

First Clinical Trial
1999
NCT00030121
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Brand's Suntory Asia | Lucozade Ribena Suntory